Procter & Gamble Co. and Teva Pharmaceutical Industries Ltd. have formed a partnership and joint venture in consumer health care. The companies said Thursday that they will develop new over-the-counter medicine brands.
Apotex Inc. has introduced Apo-Esomeprazole, a treatment for gastroesophageal reflux disease (GERD), in Canada.
Vicks VapoRub has named New Orleans Saints quarterback Drew Brees as the brand’s first-ever "VapoDad." The Procter & Gamble Co.
ProPhase Labs has added an oral spray to its Cold-EEZE line of over-the-counter homeopathic cold remedies.
Verilux, which bills itself as a "healthy lighting company," has rolled out its HappyLight Compact Energy Lamps at selected Rite Aid drug stores nationwide.
Concepts In Health Inc., the maker of MidNite Sleep Remedy, has settled a patent dispute with a store-brand manufacturer producing a private-label version of the product for a retail chain.
Start-up ShelfX has launched a wireless checkout and inventory management system for retailers that it said enables customers to shop without cashiers.
Mylan Inc. is launching morphine sulfate extended-release tablets, an opioid analgesic for the treatment of moderate to severe pain. The company said its Mylan Pharmaceuticals Inc.
Canada’s National Advisory Committee on Immunization (NACI) has designated FluMist, AstraZeneca’s nasal spray flu vaccine, as the preferred flu vaccination for children ages 2 to 17 without chronic health conditions.
Abbott has introduced Glucerna Hunger Smart nutrition shakes and nutrition bars for people with diabetes. The company said Thursday that Glucerna Hunger Smart products are specially designed for people with diabetes to use as a meal replacement or a snack as a part of a weight management plan.
Help Remedies, a maker of "minimalist" over-the-counter medicines, is hitting the shelves at Walgreens. Help Remedies’ single-ingredient OTC products are designed to provide simple solutions to basic health issues.
Teva Pharmaceutical Industries Ltd. and Dr. Reddy’s Laboratories (NYSE: RDY) announced the commercial launch of olanzapine tablets, an antipsychotic medication. The companies said Tuesday that Teva’s olanzapine tablets in dosages of 2.5 mg, 5 mg, 7.5 mg, 10 mg and 15 mg and Dr.
As of next year, Kao Brands Co. will go under a new company name: Kao USA Inc. The company said Tuesday that the name change to Kao USA is effective Jan. 1, 2012, and reflect a larger repositioning effort by its parent, Kao Corp., a leading manufacturer of beauty care and household products
Sanofi has appointed David Meeker as chief executive officer of its biotechnology subsidiary Genzyme Corp. Plans call for Meeker to take the CEO reins at Genzyme on Nov. 1, Sanofi said Monday.
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.
Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.
